Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1139 Results

Intervention Indication Therapeutic Area Year Actions
Triheptanoin for long-chain fatty acid oxidation disorders Triheptanoin (UX007; Dojolvi) Long chain fatty acid oxidation disorders (LC-FAOD) Endocrine Nutritional and Metabolic Disorders 2021 View  |  Download
Triptorelin Pamoate (subcutaneous injection) for Prostate Cancer Triptorelin Pamoate (Decapeptyl) Prostate cancer Male Reproductive Cancer 2018 View  |  Download
Trofinetide for Rett syndrome Trofinetide (NNZ-2566) Rett syndrome Genetic Disorders , Neurology 2021 View  |  Download
Troriluzole for spinocerebellar ataxia Troriluzole Spinocerebellar ataxia Genetic Disorders , Neurology 2024 View  |  Download
Tucatinib in addition to trastuzumab and capecitabine for advanced breast cancer Capecitabine (Xeloda) , Trastuzumab (Herceptin; RG-597) , Tucatinib (ONT-380) Breast cancer Breast Cancer 2020 View  |  Download
Tucatinib with trastuzumab and pertuzumab for maintenance treatment of unresectable locally advanced or metastatic HER2-positive breast cancer Pertuzumab (Perjeta; R-1273) , Trastuzumab (Herceptin; RG-597) , Tucatinib (ONT-380) Breast cancer Breast Cancer 2023 View  |  Download
Tucatinib with trastuzumab emtansine for treating unresectable, locally advanced or metastatic HER2 positive breast cancer Trastuzumab Emtansine (Kadcyla; T-DM1; PRO132365) , Tucatinib (ONT-380) Breast cancer Breast Cancer 2022 View  |  Download
Tucatinib with trastuzumab for treating colorectal cancer Trastuzumab (Herceptin; RG-597) , Tucatinib (ONT-380) Colorectal cancer Gastrointestinal Cancer 2022 View  |  Download
Tusamitamab Ravtansine for previously treated advanced Non-Small-Cell Lung Cancer Tusamitamab ravtansine (SAR408701) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Ublituximab (TG-1101) in combination with umbralisib (TGR-1202) for chronic lymphocytic leukaemia Ublituximab (TG-1101; LFB-R603) , Umbralisib (TGR-1202; RP-5264) Chronic lymphocytic leukaemia (CLL) Haematological Cancer and Lymphomas 2017 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications